Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction Between Kratom and Oxycodone
NCT05846451Phase 1Recruiting
- Sponsor
- Washington State University
- Start
- Jun 2023
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of ketum and oxycodone (4 arms), sponsored by Washington State University. Primary endpoint: Oxycodone area under the concentration vs. time curve (AUC) ratio. Started Jun 2023; status: recruiting.
02
Drugs
ketumoxycodone
Beyond the preview
Go deeper on NCT05846451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05846451.